# Characterization of the microVAScular Dysfunction in Covid-19 ARDS

> **NCT05074758** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 40 (estimated)

## Conditions studied

- ARDS, Human
- COVID-19 Acute Respiratory Distress Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** alveolar dead-space quantification
- **DIAGNOSTIC_TEST:** Coagulation activation and impaired fibrinolysis explorations
- **DIAGNOSTIC_TEST:** Endothelial activation / endothelial senescence

## Key facts

- **NCT ID:** NCT05074758
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-10
- **Primary completion:** 2022-09-10
- **Final completion:** 2022-09-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05074758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05074758, "Characterization of the microVAScular Dysfunction in Covid-19 ARDS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05074758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*